Interv Akut Kardiol. 2019;18(3):150-156 | DOI: 10.36290/kar.2018.028

Secondary tricuspid regurgitation associated with left-sided valvular disease

Zuzana Hlubocká, Gabriela Dostálová
II. interní klinika kardiologie a angiologie VFN a 1. LF UK, Praha

Tricuspid regurgitation (TR) secondary to left-sided valvular heart disease is the most frequent cause of tricuspid insufficiency. Severe mitral and aortic valve disease is associated with pulmonary hypertension and right ventricular pressure overload leading to dilatation of right ventricle (RV), dilatation of tricuspid anulus and development of secondary TR. Echocardiography is the technique of choice to evaluate aetiology of TR, quantify its severity and assess the annular dilatation, leaflet tethering , dilatation and systolic function of RV. Cardiac magnetic resonance imaging (MRI) is the gold standard in the assessment of RV volumes and ventricular function. Cardiac CT and 3D echocardiography show a good correlation with MRI in evaluation of RV. Secondary TR is severe and progressive disease. If left untreated, it leads to irreversible RV damage and right heart failure. Surgical annuloplasty with annuloplasty ring is indicated in patients undergoing left-sided valve surgery not only in severe TR but also in mild to moderate TR with annular dilatation. Isolated TR late after left-sided valvular surgery is a severe disease with high operative mortality. Development of symptoms, progression of RV dilatation or impairment of RV function are indications for redo surgery. Novel transcatheter therapies aim at restoring annular dilatation and leaflet coaptation.

Keywords: tricuspid regurgitation, valve disease, echocardiography, tricuspid valve, cardiac surgery

Received: November 5, 2018; Accepted: November 5, 2018; Published: November 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hlubocká Z, Dostálová G. Secondary tricuspid regurgitation associated with left-sided valvular disease. Interv Akut Kardiol. 2019;18(3):150-156. doi: 10.36290/kar.2018.028.
Download citation

References

  1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368(9540): 1005-1011. Go to original source... Go to PubMed...
  2. Cohen SR, Sell JE, McIntosh CL, et al. Tricuspid regurgitation in patients with acquired, chronic, pure mitral regurgitation. Prevalence, diagnosis, and comparison of preoperative clinical and hemodynamic features in patients with and without tricuspid regurgitation. J Thorac Cardiovasc Surg 1987; 94: 481-487. Go to original source...
  3. Braunwald NS, Ross J Jr, Morrow AG. Conservative management of tricuspid regurgitation in patients undergoing mitral valve replacement. Circulation 1967; 35(Suppl. 4): 163-169. Go to original source... Go to PubMed...
  4. Dreyfus GD, Corbi PJ, Chan KM, et al. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 2005; 79: 127-132. Go to original source... Go to PubMed...
  5. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38(36): 2739-2791. Go to original source... Go to PubMed...
  6. Dreyfus GD, Martin RP, Chan KMJ, Dulguerov F, Alexandrescu C. Functional tricuspid regurgitation. A need to revise our understanding. J Am Coll Cardiol 2015; 65(21): 2331-2336. Go to original source... Go to PubMed...
  7. Maeder MT, Weber L, Buser M, et al. Pulmonary hypertenstion in aortic and mitral valve disease. Front Cardiovasc Med 2018; 5: 40. Go to original source... Go to PubMed...
  8. Mas PT, Rodriguez-Palomares JF, Antunes MJ. Secondary tricuspid valve regurgitation: a forgotten entity. Heart 2015; 101: 1840-1848. Go to original source... Go to PubMed...
  9. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2014; 43: 405-409. Go to original source... Go to PubMed...
  10. Hahn RT. State-of-the-Art Review of echocardiographic imaging in the evaluation and treatment of functional tricuspid regurgitation. Circ Cardiovasc Imaging 2016; 9: e005332. Go to original source... Go to PubMed...
  11. Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Eur Heart J Cardiovasc Imaging 2013; 14(7): 611-644. Go to original source... Go to PubMed...
  12. Antunes MJ, Rodriguez-Palomares J, Prendergast B, et al. Management of tricuspid valve regurgitation. Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease. Eur J Cardiothorac Sur 2017; 52: 1022-1030. Go to original source... Go to PubMed...
  13. Topilsky Y, Tribouilloy Ch, Michelena HI, Pislaru S, Mahoney DW, Enriquez-Sarano M. Pathophysiology of tricuspid regurgitation. Quantitative Doppler echocardiographic assessment of respiratory dependence. Circulation 2010; 122: 1505-1513. Go to original source... Go to PubMed...
  14. Kim HK, Kim YJ, Park JS, et al. Determinants of the severity of functional tricuspid regurgitation. Am J Cardiol 2006; 98: 236-242. Go to original source... Go to PubMed...
  15. Dreyfus GD, Martin RP, Chan KMJ, Dulguerov F, Alexandrescu C. Functional tricuspid regurgitation. A need to revise our understanding. J Am Coll Cardiol 2015; 65(21): 2331-2336. Go to original source... Go to PubMed...
  16. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease. Eur Heart J 2010; 31: 2915-2957.
  17. Plumhans C, Mühlenbruch G, Rapaee A, et al. Assessment of global right ventricular function on 64-MDCT compared with MRI. Am J Roentgenol 2008; 190: 1358-1361. Go to original source... Go to PubMed...
  18. Topilsky Y, Nkomo VT, Vatury O, et al. Clinical outcome of isolated tricuspid regurgitation. J Am Coll Cardiol Img 2014; 7: 1185-1194. Go to original source... Go to PubMed...
  19. Ro SK, Kim JB, Jung SH, et al. Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery. J Thorac Cardiovasc Surgery 2013; 146: 1092-1097. Go to original source... Go to PubMed...
  20. McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 2004; 127(3): 674-685. Go to original source... Go to PubMed...
  21. Fukuda S, Song JM, Gillinov AM, et al. Tricuspid valve tetheringu predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation 2005; 111(8): 975-979. Go to original source... Go to PubMed...
  22. Kim YJ, Kwon DA, Kim HK, et al. Determinants of surgical outcome in patients with isolated tricuspid regurgitation. Circulation 2009; 120(17): 1672-1678. Go to original source... Go to PubMed...
  23. Parolari A., Barili F, Pilozzi A, Pacini D. Ring or suture annuloplasty for tricuspid regurgitation? A meta-analysis review. Ann Thorac Surg 2014; 98: 2255-2263. Go to original source... Go to PubMed...
  24. Fukuda S, Gillinov AM, McCarthy PM, Matsumura Y, Thomas JD, Shiota T. Echocardiographic follow-up of tricuspid annuloplasty with a new three-dimensional ring in patients with functional tricuspid regurgitation. J Am Soc Echocardiogr 2007; 20: 1236-1242. Go to original source... Go to PubMed...
  25. Bouleti C, Juliard J-M, Himbert D, et al. Tricuspid valve and percutaneous approach: No longer the forgotten valve. Archives Cardiovasc Disease 2016; 109: 55-66. Go to original source... Go to PubMed...
  26. Rodés-Cabau J, Hahn RT, Latib A, et al. Transcatheter Therapies for Treating Tricuspid Regurgitation. J Am Coll Cardiol 2016; 67(15): 1829-1845. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.